Early diagnosis, treatment best prevention for colorectal & lung cancers
The Medical City offers comprehensive diagnosis,
treatment modalities for colorectal, lung cancers
The World Health Organization (WHO) says the early detection of cancer
greatly increases the chances for its successful treatment. Recognizing the
warning signs of cancer and taking prompt consultation usually leads to early
diagnosis and treatment. Providing health professionals and the public with an
awareness of the early signs of cancer will have a great impact in addressing
the illness. In fact, early diagnosis is relevant to specific types of cancer,
namely those affecting the breast, cervix, mouth, larynx, colon and rectum,
lung and skin.
Cancer Research UK, a leading global charity dedicated to beating
cancer through research, says the early diagnosis of cancer means it can be
easily removed or treated. The late diagnosis of cancer makes treatment
difficult and lowers a person’s chances of surviving the illness. It estimates
that as much as 10,000 deaths from cancer could be prevented with early
diagnosis and treatment.
The Philippine Cancer Society lists lung cancer as the leading cause
of deaths from cancer in the country. In 2010, a total of 11,458 cases were
reported, while there were 9,184 deaths. Colorectal cancer, on the other hand, ranks
no.4 in terms of cancer deaths. In the same year, 5,787 cases were recorded,
while deaths due to colorectal cancer reached 3,060 cases.
The Medical City Cancer
Program
The Medical City (TMC) Cancer Program, organized in 2006, adopts a
unique multidisciplinary team approach to cancer prevention, early detection,
diagnosis, and management. It applies innovative molecular technologies in
diagnosis and treatment for a truly customized and personalized care.
With a full appreciation that no two individuals are alike, regardless
of similarities between two patients diagnosed with the same type of cancer,
TMC Cancer Program applies an individualized approach to cancer diagnosis and
treatment based on the patient’s profile and history.
With this, a personalized treatment plan according to the profile and
preferences of the patient is developed by a multidisciplinary team. The highly
trained medical team includes cancer specialists, nurses and other specialized
health care professionals. Family members are also an important part of this.
Central to everyone, the focus of our cancer program is the patient.
Colorectal Cancer
Colorectal cancer is among the top five most common cancers in the
country today. Recent studies showed that the Philippines has a higher
colorectal cancer mortality compared to other countries. Colorectal cancer is
cancer that starts in either the colon or the rectum.
Colorectal cancer ranks fourth among cancer-related deaths in
Filipinos. According to the Philippine Cancer Society, Inc., almost 75 percent
of the individuals affected were aged 50 and above, while only about three
percent were children 14 years old and below. It is estimated that one out of 1,800
Filipinos will develop the cancer yearly.
Dr. Ramy Roxas, head of TMC’s Colorectal Clinic, says, “With good
screening and early diagnosis, 90 percent of colorectal cancers are
curable."
Early screening and a multi-modality treatment such as chemotherapy,
pre-operative radiotherapy and surgery are among the factors responsible for
improving colorectal cancer outcomes.
TMC’s Colorectal Clinic offers cancer-screening tests, including FOBT,
diagnostic and therapeutic flexible sigmoidoscopy, and colonoscopy. “Colonoscopy
is one of the most unloved cancer tests, but it can save lives. It is the most
accurate test for colorectal cancer,” says Dr. Roxas.
He explains a fecal occult blood test (FOBT) is recommended for
everyone aged 50 and above. This test should be done every year after age 50.
The other alternative is to undergo colonoscopy every five to 10 years. Those
with a strong family history of colorectal cancer or those with two or more
family members who had the disease should be screened earlier, ideally 10 years
before the age of diagnosis of their relatives with colorectal cancer.
In fact, the WHO says research on the efficacy of FOBT for screening saw a reduction
of up to 20 percent in colorectal cancer mortality from biennial screening, and
a greater reduction as a result of annual screening.
TMC’s Colorectal Clinic provides expert diagnoses and multimodality
treatments for colorectal cancer, including chemotherapy, radiotherapy, and
surgery. The clinic promotes minimally invasive procedures for early cases, as
well as radical operations for advanced and recurrent cases. Laparoscopic
surgery, trans-anal endoscopic microsurgery, and robotic-assisted surgery are
among the minimally invasive procedures being offered by the clinic.
Among all private hospitals in the Philippines, TMC’s Colorectal
Clinic has performed the greatest number of preoperative chemo-radiotherapy for
rectal cancers and minimally invasive laparoscopic colorectal cancer
procedures, including robotic surgery. It also boasts the greatest number of
patients in a private hospital setting with complete pathologic response
following neoadjuvant chemo-radiotherapy for rectal cancer, and the highest
anal sphincter.
TMC’s Colorectal Clinic also caters to patients with anorectal
diseases, such as hemorrhoids, perianal infection, fistula, fissures, and fecal
incontinence to name a few. It offers various treatment options for
hemorrhoids, such as rubber band ligation, transanal hemorrhoidal
dearterialization (THD), and stapled hemorrhoidectomy, which are proven to be
less painful procedures than traditional surgery.
The Medical City’s Colorectal Clinic is managed by a nationally
renowned team of board-certified experts. It is located at the second floor of
the Nursing Tower. For details, call 988-1000 or 988-7000 ext. 6214.
Lung Cancer
Lung cancer is the leading cause of cancer
deaths worldwide in both men and women, with more
than one million deaths recorded annually. However, most cases are
detected during their advanced stages when patients are already symptomatic,
and their chances of survival are very low.
TMC has a Lung Cancer Program that aims to detect the disease
early in high-risk individuals and to provide optimal options for
management of both early and advanced stages.
Among the latest options TMC uses for screening lung cancer is the
Endobronchial Ultrasound (EBUS), a state of the art minimally
invasive procedure used in the diagnosis of lung cancer,
infections, and other inflammatory diseases in the chest. Presently, TMC is the
first and currently the only hospital in the country to offer EBUS.
“With EBUS as an additional diagnostic option for high-risk
patients, we are expecting to increase detection rates of early stage lung
cancer, which may be salvageable by surgery and has good prognosis. In
addition, EBUS can aid in the diagnosis of benign diseases that need specific
pathologic confirmation,” says Dr. Christine Chavez, interventional pulmonologist
and head of the Lung Unit of TMC Center for Cancer Care and
Research.
EBUS assists patients and doctors by shortening the
time from diagnosis to treatment. EBUS is a procedure that incorporates
ultrasound technology in bronchoscopy. By means of a small video
device, it allows bronchoscopists to view lung
abnormalities through and beyond the surface of the airways for real-time image
guidance during procedures; hence, higher degree of diagnostic accuracy and
safety is possible.
With real-time imaging and ultrasound guidance, doctors can map,
evaluate, and safely biopsy tumors and lymph nodes. This procedure is called
EBUS-transbronchial needle aspiration, or EBUS-TBNA, which results
in accurate diagnosis and staging of the lung cancer
and detection of other causes of pulmonary mass such as tuberculosis,
sarcoidosis and lymphoma.
Comments
Post a Comment